NOVALIS LIFESCIENCES

novalis-lifesciences-logo

Novalis Lifesciences LLC, is a globally acting venture capital firm focused on breakthrough technologies in Life Science. Founded and managed by Dr. Marijn E. Dekkers, current chairman of Unilever and former chief executive officer of Bayer AG and Thermo Fisher Scientific Inc., Novalis works with a diversified group of project-based specialists leading in their respective life science fields

#SimilarOrganizations #People #Financial #More

NOVALIS LIFESCIENCES

Founded:
2017-01-01

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Euro Google Apps For Business Typekit Squarespace


Similar Organizations

polycore-therapeutics-logo

PolyCore Therapeutics

PolyCore Therapeuticsโ€™ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.

section-32-logo

Section 32

Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.

Current Employees Featured

marijn-dekkers_image

Marijn Dekkers
Marijn Dekkers Chairman/Founder @ Novalis LifeSciences
Chairman/Founder

Founder


marijn-dekkers_image

Marijn Dekkers

Investments List

Date Company Article Money raised
2022-08-23 eTheRNA immunotherapies Novalis LifeSciences investment in Series B - eTheRNA immunotherapies 39 M EUR
2022-07-28 Animol Discovery Novalis LifeSciences investment in Series B - Animol Discovery 34 M USD
2022-07-27 Enko Chem Novalis LifeSciences investment in Series C - Enko Chem 70 M USD
2022-06-03 Vizgen Novalis LifeSciences investment in Series C - Vizgen 85.2 M USD
2022-03-08 Sherlock Biosciences Novalis LifeSciences investment in Series B - Sherlock Biosciences 80 M USD
2022-01-18 Ori Biotech Novalis LifeSciences investment in Series B - Ori Biotech 100 M USD
2021-12-21 SkylineDx Novalis LifeSciences investment in Venture Round - SkylineDx N/A
2021-09-14 AgBiome Novalis LifeSciences investment in Series D - AgBiome 116 M USD
2021-04-07 Vizgen Novalis LifeSciences investment in Series B - Vizgen 37 M USD
2020-07-29 Cerevel Therapeutics Novalis LifeSciences investment in Post-IPO Equity - Cerevel Therapeutics 320 M USD

More informations about "Novalis LifeSciences" on Search Engine